Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S046 - Boards Blitz

Monday, February 19; 9:00 AM - 12:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize and/or diagnose commonly tested images related to medical dermatology, pediatric dermatology, surgical dermatology, and clinical pathologic correlates.
  • Identify strengths and weaknesses in one's fund of knowledge to better prepare for the ABD certification exam and/or in-training exam and make improvements as needed.

Description

The in-training and board certification exams all require a mastery of a broad breadth of information as dictated by the American Board of Dermatology (ABD) – overwhelmed yet? This interactive session will provide key points and tips for identifying and answering questions on the digital image portion of the certification/recertification exams. Attendees will have the opportunity to view numerous digital images with associated questions preparing them for the kodachrome portion of the exam. High-yield study material will also be covered as the images are reviewed. The session will benefit any dermatologist preparing for the ABD certification, recertification, or in-training exam.

Disclosures

  • Finch, Justin J., MD: no financial relationships exist with commercial interests.
  • Friedman, Adam J., MD: Aclaris Therapeutics Inc. – I(Grants/Research Funding); Allergan, Inc. – Speaker/Faculty Education(H); Amgen – A(H), Speaker/Faculty Education(H); Bayer – SP(H); Biogen – A(H); Dermira – C(H); Eli Lilly and Company – C(H); Encore Dermatology, Inc. – C(H); Exeltis – C(H); Galderma USA – C(H); IntraDerm Pharmaceuticals – C(H); Janssen Biotech – SP(H), Speaker/Faculty Education(H); Johnson and Johnson Consumer Products Company – C(H); La Roche-Posay Laboratorie Pharmaceutique – A(H); Medscape – Speaker/Faculty Education(H); Menlo Therapeutics – A(H); Novartis – A(H); Oculus innovative Sciences, Inc. – C(H); Orlando Dermatology Aesthetic & Clinical (ODAC) – SP(H); Pfizer Inc. – C(H); Promius Pharma, LLC – A(H), SP(H); Regeneron – Speaker/Faculty Education(H); Sanova Works – C(H); Valeant Pharmaceuticals International – I(Grants/Research Funding); Valeant Pharmaceuticals North America LLC – A(H);
  • Lee, Bonnie Anne, MD: no financial relationships exist with commercial interests.
  • Lucas, Jennifer, MD: no financial relationships exist with commercial interests.
  • Marathe, Kalyani, MD, MPH: Eli Lilly and Company – I(Grants/Research Funding); Sanova Works – Independent Contractor(H);
Schedule
Monday, February 19
9:00 AM
Dr. Kirkorian and Dr. Marathe / Pediatric Dermatology
9:35 AM
Dr. Lucas / Procedural Dermatology
10:10 AM
Dr. Friedman / General and Medical Dermatology
10:45 AM
Dr. Lee / Dermatopathology
11:20 AM
Dr. Finch / General and Medical Dermatology
Event Details
  • Date
    Monday, February 19
  • Time
    9:00 AM - 12:00 PM
  • Location
    Room 6A
  • CME Credits
    3.00
  • Type
Directors/Co-Directors
  • Justin J. Finch, MD, FAAD
  • Adam J. Friedman, MD, FAAD
  • Jennifer Lucas, MD, FAAD
Speakers
  • Bonnie Anne Lee, MD, FAAD
  • Kalyani Marathe, MD, MPH, FAAD